NetraMark recently reiterated its goal to attain C$8m - $10m in contract backlog by mid-2026 & remains focused on forming new contracts, shortening sales cycles and helping sponsors de-risk late-stage trials. Among the multiple partnerships formed in 2025 expected to contribute to backlog and revenue, NetraMark completed onboarding with global CRO Worldwide Clinical Trial & can now be included in Worldwide's trial bids, an important factor expected to contribute to the contract backlog target. As AINMF continues to build awareness of its capabilities, last quarter the company announced pending publication of its peer-reviewed scientific study highlighting NetraAI & collaboration with the Centre for Addiction and Mental Health.
